TABLE 3.
Comparative in-hospital outcome of patients admitted with pulmonary embolism with and without concurrent COVID-19 infection
| Outcomes | PE with COVID-19 | PE without COVID-19 | aOR/aIRR* | 95% CI | p-value |
|---|---|---|---|---|---|
| In-hospital Mortality | (4.69%) | (3.04%) | 1.62 | 1.17-2.24 | 0.004 |
| Cardiogenic shock | 65 (1.42%) | 4950 (1.8%) | 0.80 | 0.43-1.47 | 0.465 |
| IABP | 10 (0.22%) | 840 (0.31%) | 0.79 | 0.20-3.17 | 0.742 |
| NSTEMI | 105 (2.29%) | 10,525 (3.84%) | 0.65 | 0.42-1.02 | 0.062 |
| Ischemic stroke | 60 (1.31%) | 3370 (1.23%) | 1.07 | 0.60-1.89 | 0.824 |
| Septic shock | 125 (2.73%) | 4430 (1.62%) | 1.66 | 1.10-2.52 | 0.016 |
| Acute kidney injury | 610 (13.32%) | 41,315 (15.06%) | 0.95 | 0.78-1.17 | 0.660 |
| Respiratory failure | 1470 (32.1%) | 62,560 (22.81%) | 1.78 | 1.53-2.06 | 0.001 |
| RF with intubation | 20 (0.44%) | 490 (0.18%) | 2.48 | 0.88-6.98 | 0.084 |
| Length of Stay | 5.5 days | 4.59 days | 1.23* | 1.14-1.33 | 0.001 |
| Average patient charges, USD | $ 74,313.4 | $80,012.2 | 0.95* | 0.86-1.04 | 0.281 |
aOR, adjusted odd ratio, aIRR, adjusted incidence rate ratio, aMD, adjusted mean difference, CI, confidence interval.
Outcomes adjusted for age, gender, race, insurance status, hospital characteristics (teaching status, & bed size), baseline oxygen use, anticoagulation and antiplatelet use, nicotine use, and comorbidities measured using the Elixhauser comorbidity index.